Pazopanib-induced asymptomatic radiological acute pancreatitis: A case report
Baraibar I (1), Quílez A (2), Salas D (1), Román M (1), Rolfo C (3), Pérez-Gracia JL (1), Gil-Bazo I (1).
(1) Department of Oncology, Clínica Universidad de Navarra, Pamplona, Spain.
(2) Department of Radiology, Clínica Universidad de Navarra, Pamplona, Spain.
(3) Phase I - Early Clinical Trials Unit, Antwerp University Hospital, Edegem, Belgium.
Magazine: Molecular and Clinical Oncology
Date: May 22, 2017Medical Oncology
The universal clinical use of multi-targeted tyrosine kinase inhibitors (TKIs) in patients diagnosed with advanced renal cell carcinoma (RCC) has significantly prolonged their estimated survival times and their quality of life.
However, several adverse side-effects associated predominantly with the inhibition of the vascular endothelial growth factor receptor by these drugs may prove to be potentially life-threatening.
One adverse event that is only rarely observed with the use of TKIs in this clinical setting is acute pancreatitis. In the present study, to the best of our knowledge, the first case of asymptomatic radiological acute pancreatitis associated with the use of pazopanib in monotherapy in a patient with RCC is presented. In addition, a comprehensive review of the literature on this topic is provided, and certain potential measures that may aid in early diagnosis and treatment are discussed.
CITATION Mol Clin Oncol. 2017 May;6(5):651-654. doi: 10.3892/mco.2017.1210. Epub 2017 Apr 6.
you maybe interested
The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.
The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.
Learn why we are different from other healthcare centers. Quality, speed, comfort and results.